# Clearsense

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/clearsense

- Industry: Healthcare IT
- Headquarters: Jacksonville, US
- Website: www.clearsense.com
- Total disclosed funding: $50M
- Latest round: Series D (Jan 30, 2023)
- Investors on record: 3

## About

Clearsense, LLC is a US-based company specializing in healthcare data management, providing an enterprise platform that enhances operational efficiency and data-driven decision-making for healthcare organizations.Founded in 2014, Clearsense, LLC is based in Jacksonville, US and focuses on providing a comprehensive healthcare data platform. The company has successfully closed three deals to date and raised a total of USD 50.00 mn in funding, with the most recent Series D round completed on January 30, 2023. The funding round was led by HealthQuest Capital, with additional investment from Health Catalyst Capital Management and UPMC Enterprises. The firm was co-founded by Charles Boicey and Jason Mabry, with Jason Rose currently serving as the CEO.Clearsense offers a comprehensive enterprise healthcare data platform designed to streamline operations in the healthcare sector. The core product, the 1Clearsense Platform, integrates data from various sources, enabling healthcare organizations to achieve a centralized view of their data, thereby enhancing operational efficiency and decision-making processes. The platform supports active data archiving and the establishment of healthcare data lakehouses, addressing critical needs in revenue recovery and maximizing clinical trial revenues. The target customers include hospitals and health systems, with usage extending across the United States and potential expansion into other global markets. End users include healthcare administrators, data analysts, and clinical researchers who benefit from improved workflows and easier access to essential data insights.Clearsense generates revenue through a subscription-based model, wherein healthcare organizations pay for access to the 1Clearsense Platform and its suite of services. This model allows for scalable pricing structures that can vary based on the size of the client organization and the specific services utilized. Key offerings, including Active Data Archiving and Healthcare Data Lakehouse solutions, are part of these subscriptions, providing tailored solutions for unique data management needs. The company's revenue streams are derived primarily from direct engagements with B2B clients in the healthcare sector, leveraging the platform to optimize data usage and drive cost savings. Reports indicate that 100% of Clearsense customers would choose to make a repeat purchase based on their experience with the platform.In January 2023, Clearsense raised USD 50.00 mn in Series D funding to strengthen its mission and enable data-driven decision-making. The company plans to use the recent funding to support the development of new products and expand into new markets. Specific geographic regions targeted for expansion include international healthcare markets, aiming to broaden their reach by 2024. The company is focused on enhancing its platform capabilities to meet the evolving needs of healthcare organizations.

## Funding rounds

- Series D, Jan 30, 2023, $50M — HealthQuest Capital, Health Catalyst Capital Management, UPMC Enterprises

## Investors

- HealthQuest Capital (https://capitalatlas.ai/funds/healthquest-capital) — Series D
- Health Catalyst Capital Management (https://capitalatlas.ai/funds/health-catalyst-capital-management) — Series D
- UPMC Enterprises (https://capitalatlas.ai/funds/upmc-enterprises) — Series D